Akari Therapeutics Releases CEO Corner Highlighting Strategic Progress and Path to Clinical Development Under CEO Abizer Gaslightwala March 13, 2026
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update March 12, 2026
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences March 12, 2026
Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone March 11, 2026